Steerable Sheath Market Size, Share, and Industry Analysis, By Product Type (Unidirectional, Bi-directional, and Multidirectional), By Application (Electrophysiology Procedures, Interventional Cardiology Procedures, Peripheral Vascular Procedures, and Others), By End User (Hospitals, Specialty Clinics, Diagnostic Centers, and Others), and Regional Forecast, 2026-2034

The global steerable sheath market size was valued at USD 0.94 billion in 2025. The market is projected to grow from USD 1.01 billion in 2026 to USD 1.78 billion by 2034, exhibiting a CAGR of 7.34% during the forecast period.

The global steerable sheath market is witnessing significant growth owing to the increasing prevalence of cardiovascular disorders, and others, resulting in research and development activities among the key players to develop and introduce novel products in the market. Steerable sheaths are medical devices that facilitate access to hard-to-reach sites in cardiovascular procedures including electrophysiology procedures, interventional cardiology procedures, and others among the patient population.

• According to 2023 data published by PCROnline, it was reported that about 620 million people are suffering from cardiovascular disorders worldwide.

Steerable Sheath Market Driver

Increasing Number of Cardiovascular Procedures to Drive Market Growth

The increasing prevalence of cardiovascular disorders is resulting in the growing number of surgical procedures among the patient population. This, along with the growing focus of the key players to launch innovative products, is expected to contribute to the increasing adoption rate for these products.

• According to 2024 statistics published by Science Direct, about 1 to 1.5 million cardiovascular surgeries are performed each year globally.

Download Free sample to learn more about this report.

According to 2022 data published by the Organisation for Economic Co-operation and Development (OECD), it was reported that the number of cardiovascular procedures performed was 900,000 in the U.S., 95,238 in the U.K., 89,398 in Canada, and 85,494 in France.

Steerable Sheath Market Restraint

Limited Healthcare Facilities in Developing Countries Hinder Market Growth

There is a growing demand for novel steerable sheaths to perform cardiovascular procedures among healthcare facilities globally. However, the limited availability of healthcare facilities along with inadequate reimbursement policies, among others is expected to limit the adoption rate for these products in the market.

• According to 2023 data published by The Economic Times, there are about 70,000 hospitals in India.

Steerable Sheath Market Opportunity

Increased Preference for Minimally Invasive Procedures to Bolster Market Growth Potential

There is an increasing preference toward minimally invasive surgical procedures owing to the benefits such as reduced hospital stay, reduced risk of infection, and faster recovery, among others, resulting in a growing number of surgical procedures, further expected to support the adoption rate for these products globally.

• According to 2023 statistics published by the North Kansas City Hospital, nearly 15 million laparoscopic procedures are performed each year in the U.S.

Segmentation

Key Insights

The report covers the following key insights:

• Prevalence of Key Disorders, By Key Countries/Regions, 2023
• Number of Cardiovascular Surgical Procedures, By Key Countries/Regions, 2023
• New Product Launches, By Key Players
• Key Industry Developments (Mergers, Acquisitions, and Partnerships)
• Impact of COVID-19 on the Market

Analysis by Product Type

Amongst product type, the market is subdivided into unidirectional, bidirectional, and multidirectional.

The bi-directional segment held the prominent proportion of the market share in 2023. The increasing focus of key players toward R&D initiatives to launch bi-directional steerable sheaths is expected to support the segmental growth in the market.

• In April 2022, Abbott launched a bi-directional Amplatzer steerable delivery sheath with an aim to strengthen its product offering in the U.S.

Analysis by Application

Based on application, the market is subdivided into electrophysiology procedures, interventional cardiology procedures, peripheral vascular procedures, and others.

The electrophysiology procedures segment accounted for a substantial market share in 2023. The segmental growth is due to the growing prevalence of cardiovascular disorders resulting in increasing electrophysiology procedures performed among the patient population globally.

• According to statistics published by the National Center for Biotechnology Information (NCBI), the annual rate of all cardiac electrophysiology procedures increased from 817.91 in 2019 to 1089.68 in 2023 per 1,000 patients in the U.S.

Analysis by End User

On the basis of end user, the market is divided into hospitals, specialty clinics, diagnostic centers, and others.

The hospitals segment accounted for a significant proportion of the market in 2023. The growth is due to the growing number of ASCs, further supporting the rising patient admissions globally. The increasing number of patient admissions and surgical procedures is contributing to the surge in demand for steerable sheaths in the market, thereby supporting segmental growth.

• According to 2023 data published by the U.S. Ambulatory Surgery Center Market Report, there are about 11,780 ambulatory surgical centers in the U.S.

Regional Analysis

To gain extensive insights into the market, Download for Customization

Based on region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America accounts for the largest share of the global steerable sheath market in 2023. The growth is due to several factors, including the growing prevalence of cardiovascular disorders, the growing number of surgical procedures, and the increasing number of product launches, among others.

• According to 2019 statistics published by the American Heart Association, it was reported that about 48% of adults are suffering from cardiovascular disease in the U.S.

Additionally, Europe is the second-largest market for steerable sheaths. The rising prevalence of cardiovascular conditions is further contributing to the growing demand for novel steerable sheaths in the market. This, along with the rising focus of key players toward inorganic growth strategies such as acquisitions and mergers, expansions, among others, is further likely to support the growth of the market in the region.

• According to data published by Eurostat, there were 1.1 million transluminal coronary angioplasty procedures in 25 European countries in 2021.

Asia Pacific is also expected to grow at a considerable CAGR during the forecast period. The growth is owing to the rising number of surgical procedures in the countries such as India, China, and others along with increasing number of prominent players operating in the market offering novel steerable sheaths.

Key Players Covered

The global steerable sheath market is fragmented, with many players operating in the global steerable sheath market.

The report includes the profiles of the following key players:

• Abbott (U.S.)
• Serpex Medical (U.S.)
• Boston Scientific Corporation (U.S.)
• Stryker (U.S.)
• Baylis Medical (Canada)
• Medtronic (Ireland)
• Integer Holdings Corporation (U.S.)
• Merit Medical Systems (U.S.)

Key Industry Developments

• In February 2024, Integer Holdings Corporation presented a range of key product areas including steerable introducers and sheaths, therapy delivery systems, among others. This helped the company to increase its brand presence globally.
• In August 2022, Serpex Medical received U.S. FDA approval for its Recon Steerable Sheath, a steerable endobronchial tool that enables physicians to access transbronchial areas.